Partner Content Partner Content How to fix your adherence problem Typical patient support programs fail to improve adherence - and it’s costing the pharma industry billions. Here’s how to do a better job.
Views & Analysis Rare disease market research needs a multifaceted approach Challenges in rare disease market research and the role of online research.
Views & Analysis What does your pharma brand mean to patients? Pharma companies can differentiate themselves and win support if they take actions that patients find informative.
Views & Analysis Six factors shaping healthcare in emerging markets The factors shaping the healthcare landscape in emerging markets.
News Allergy Tx plots grass pollen jab launch after German okay Allergy Therapeutics has had its grass pollen allergy treatment Grassmuno approved in Germany, its first market, setting up a launch early next year.
Sales & Marketing Sponsored The AI imperative: Establishing the standard for modern clin... The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.
